Adam S. Kittai

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “An indirect comparison of acalabrutinib with and without obinutuzumab vs zanubrutinib in treatment-naive CLL”.

An indirect comparison of acalabrutinib with and without obinutuzumab vs zanubrutinib in treatment-naive CLL

Blood Advances(2024)10.1182/bloodadvances.2023012142

N/A

0.569DataRank · unranked

18 citations

John N. Allan, Dan James, Helen Bridge, Miguel Miranda, Alan SM Yong +6 more

International consensus statement on diagnosis, evaluation, and research of Richter transformation: the ERIC recommendations

Blood(2025)10.1182/blood.2024028064

N/A

0.425DataRank · unranked

16 citations

Monia Marchetti, Othman Al‐Sawaf, Ohad Benjamini, Alexey V. Danilov, Matthew S. Davids +24 more

Cardiovascular Toxicities of BTK Inhibitors in Chronic Lymphocytic Leukemia

JACC CardioOncology(2023)10.1016/j.jaccao.2023.09.002

N/A

0DataRank · unranked

115 citations

Sanam Ghazi, Aneeq Yasin, Farrukh T. Awan, Michael G. Fradley, Tracy Wiczer +16 more

TRES, a validated three-factor comorbidity score, is associated with survival in older patients with mantle cell lymphoma

Haematologica(2023)10.3324/haematol.2023.283074

N/A

0DataRank · unranked

0 citations

David A. Bond, Adam S. Kittai, Neda Amirmokhtari, Abigail Steinbrunner, Allison Huffman +6 more

Atrial fibrillation burden and clinical outcomes following BTK inhibitor initiation

Leukemia(2024)10.1038/s41375-024-02334-3

N/A

0DataRank · unranked

16 citations

Sanam Ghazi, Stephen Sansoterra, Mussammat Ferdousi, Onaopepo Kola‐Kehinde, Patrick Ruz +9 more

Outcomes of CD19 CAR T in Transformed Indolent Lymphoma Compared to De Novo Aggressive Large B‐Cell Lymphoma

American Journal of Hematology(2024)10.1002/ajh.27548

N/A

0DataRank · unranked

13 citations

Reid W. Merryman, Yan Wang, Charles Gaulin, Evandro D. Bezerra, Timothy Voorhees +16 more

Outcomes of patients with Richter transformation who received no prior chemoimmunotherapy for their CLL

Blood Cancer Journal(2025)10.1038/s41408-025-01236-6

N/A

0DataRank · unranked

12 citations

Ying Huang, Sarah Miller, John N. Allan, Seema A. Bhat, David A. Bond +40 more

NEDD8-activating enzyme inhibition induces cell cycle arrest and anaphase catastrophe in malignant T-cells

Oncotarget(2021)10.18632/oncotarget.28063

N/A

0DataRank · unranked

8 citations

Olga V. Danilova, Vi Lam, Tingting Liu, Nur Bruss, Scott Best +3 more

New comorbidity index associated with survival after chimeric antigen receptor T-cell therapy for large B-cell lymphoma

Blood Advances(2025)10.1182/bloodadvances.2024015599

N/A

0DataRank · unranked

5 citations

Hamza Hashmi, Mahmoud Elsawy, Soyoung Kim, Amy Moskop, Temitope Oloyede +40 more

Hypertension and incident cardiovascular events after next-generation BTKi therapy initiation

Journal of Hematology & Oncology(2022)10.1186/s13045-022-01302-7

N/A

0DataRank · unranked

39 citations

Leylah Azali, Lindsay Rosen, Qiuhong Zhao, Tracy Wiczer, Marilly Palettas +13 more